Northstar Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.4M Buy
9,936
+243
+3% +$59.8K 0.32% 75
2021
Q1
$2.41M Buy
9,693
+2,362
+32% +$564K 0.35% 71
2020
Q4
$1.69M Sell
7,331
-20,326
-73% -$4.69M 0.26% 75
2020
Q3
$7.03M Buy
27,657
+15,574
+129% +$3.86M 1.26% 28
2020
Q2
$2.85M Buy
12,083
+9,783
+425% +$2.23M 0.6% 52
2020
Q1
$466K Buy
2,300
+300
+15% +$65.5K 0.12% 88
2019
Q4
$482K Hold
2,000
0.08% 109
2019
Q3
$417K Buy
+2,000
New +$384K 0.07% 105
2019
Q2
Sell
-1,270
Closed -$241K 120
2019
Q1
$241K Sell
1,270
-520
-29% -$99.3K 0.04% 113
2018
Q4
$348K Sell
1,790
-100
-5% -$19.5K 0.08% 94
2018
Q3
$392K Buy
1,890
+25
+1% +$4.93K 0.08% 84
2018
Q2
$344K Buy
1,865
+390
+26% +$69K 0.07% 90
2018
Q1
$251K Buy
1,475
+80
+6% +$14.7K 0.05% 99
2017
Q4
$243K Buy
1,395
+140
+11% +$24.8K 0.04% 107
2017
Q3
$234K Hold
1,255
0.05% 112
2017
Q2
$216K Buy
+1,255
New +$204K 0.04% 106

Other funds holding AMGN

Northstar Investment Advisors's AMGN Position: Q2 2021 in Review

Northstar Investment Advisors increased its Amgen (AMGN) stake by 2.5% in Q2 2021, buying an estimated $59.8K and bringing the position to 9,936 shares worth $2.4M. The position accounts for 0.32% of the portfolio, ranked #75.

Northstar Investment Advisors first reported a position in AMGN in Q2 2017 and has held it in 16 quarters since. The position peaked at $7.03M in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Northstar Investment Advisors held 9,936 shares of Amgen worth $2.4M as of Q2 2021.
  • Northstar Investment Advisors bought 243 Amgen shares in Q2 2021, an estimated $59.8K.
  • Amgen made up 0.32% of Northstar Investment Advisors's portfolio in Q2 2021, its #75 holding.
  • Northstar Investment Advisors first reported a position in Amgen in Q2 2017 and has held it in 16 quarters since.
  • Northstar Investment Advisors's Amgen position peaked at $7.03M in Q3 2020.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Northstar Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.